1.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 06U.20, 2005-84, NCT00429143
|
|
2.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 to 70 Sponsor: Other Protocol IDs: BMT109, 75190, NCT00185614
|
|
3.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: AZARELA_HHU_2007, NCT00795548
|
|
4.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: Under 70 Sponsor: NCI Protocol IDs: CALGB-100601, CALGB-100601, NCT01118013
|
|
5.
|
Phase: Phase II Type: Treatment Status: Closed Age: 2 and over Sponsor: Other Protocol IDs: 2010LS010, MT2010-02, 1003M79954, NCT01106950
|
|
6.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 to 70 Sponsor: Other Protocol IDs: UPCC 08405, NCT00374933
|
|
7.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 00005124, NCT00586690
|
|
8.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 00005123, NCT00586703
|
|
9.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 07-193, NCT00675831
|
|
10.
|
Phase: Phase I Type: Treatment Status: Closed Age: Not specified Sponsor: Other Protocol IDs: 2003-0564, NCT00866346
|
|
11.
|
Phase: Phase I Type: Supportive care Status: Closed Age: 18 to 75 Sponsor: NCI Protocol IDs: 990143, 99-C-0143, NCT00001830
|